In this study, aloe fermentation products were derived from mycelia from 3 mushrooms: Ganoderma lucidum (AG), Hericium erinaceum (AH), and Phellinus linteus (AP). Levels of aloin A and B increased with fermentation time. The highest levels were measured on the fifth day of fermentation. β-Glucan levels decreased with fermentation time. The safety of aloe fermentation products were examined in male and female Sprague-Dawley rats. Rats were orally administered the three aloe fermentation products at dose levels of 1, 2 or 5 g/kg for single-dose toxicity test and 0.5, 1, or 2 g/kg for repeated-dose toxicity test. There were no significant differences in body weight gain between vehicle control and AG-, AH-or AP-treated rats. Also, significant changes in daily feed intake and water consumption were not observed. In hematological analysis, none of the parameters were affected by aloe fermentation products with mushroom mycelia. This suggests that there are no negative effects on homeostasis and immunity. In blood biochemistry analysis, none of the markers were affected by feeding rats with AG, AH or AP. Similarly, there were no significant effects on markers for liver, kidney, skeletal and heart muscle functions. No remarkable lesions were observed in these organs at histopathology. Since there were no adverse effects of AG, AH and AP in single-or repeated-dose toxicity tests, even at higher doses than normal, we conclude that the aloe fermentation products with mushroom mycelia possess long-term safety and could be candidates as multifunctional nutrients for the improvement of intestinal function and immunity.
Single-and repeated-dose toxicities of aloe fermentation products in rats
Mushrooms contain a greater variety of nutrition (such as carbohydrates, protein, vitamins and minerals) than vegetables. They have been used as food and medicine since ancient times and are regarded by some people as a favorite food on account of their unique taste and flavor [7] . Recently, there have been many scientific studies on the ability of mushrooms to improve immunity, lower cholesterol, normalize blood-sugar levels, and to have anti-cancer, anti-microbial and antihypertensive effects [8] [9] [10] [11] [12] [13] . In particular, a liquid culture method using the mushroom mycelium, which enables the production of large amounts of bioactive compounds in a short period of time and at lower cost, has been studied for possible utilization on an industrial scale. Ganoderma lucidum, which was used in our study, is in the Polyporaceae of basidiomycetes family and is used a diuretic, a tonic, and for improving immunity against anti-cancer [11, [14] [15] [16] . It was proven safe in an animal experiment of acute and subacute toxicity using extracts of the whole plant. The second mushroom used in this study, Hericium erinaceum, has also been used as food and medicine for a long time. It is effective in chronic gastritis, cancer (especially gastric cancer), and in physical weakness. In a recent study, material for a potential Alzheimer cure was extracted into hot water from Hericium erinaceum. The hot-water extract also had anti-tumor effects -it restricted cancer cell proliferation. Hericium erinaceum contains β-glucan, which enhances immunity and prevents arteriosclerosis [17] [18] [19] . The third mushroom used in this study is Phellinus linteus. It is effective in improving immunity during chemotheraphy after cancer surgery, especially for gastrointestinal malignancies such as stomach, esophagus, duodenum, colon, rectum and liver cancers. It also has effects on metrorrhagia, leukorrhea, irregular menstruation, enterohemorrhage. It improves stomach function and can be used for detoxification [16] .
There have been no reports on the nutritional and toxic effects of products from the above mushrooms that have been fermented in aloe. In this study, we examined a new and improved functional material of aloe fermented using mushroom strains. For safety evaluation and standardization of the fermentation products, single-dose and repeated-dose toxicity tests were performed with the standard being toxicity tests of KFDA (Regulation 1999-61).
Materials and Methods

Experimental animals
Male and female healthy Sprague-Dawley rats (150-200 g), from Daehan Bio-Link Inc. (Eumsung, Korea), were used after 1-week acclimation to the laboratory environment. The experiment was performed in the animal laboratory under conditions of 23±3 o C, a relative humidity of 55±15%, 12 h of lighting (08:00-20:00) at 150-300 Lux of brightness. During the experimental period, the rats were kept in stainless mesh cages (220W×410L×200H mm). Two to three rats in each cage were kept for the adjustment, during the test product administration and observation periods. The animal experiments were performed with permission from The Ethics Committee of Animal Experiments at Chungbuk National University, Korea.
Materials
Ganoderma lucidum (KCTC 6729) and Phellinus linteus (KCTC 6719) were used as standard strains. They were acquired from the Gene Bank of The Korea Biological Resource Center. Hericium erinaceum was obtained from the Food-Engineering Department of Chungju National University (Jeungpyeong, Korea). Each strain was cultivated in potato dextrose agar (PDA, Difco, Detroit, USA) by 15 days of subculturing [18, 20] . Aloe (Aloe vera) was purchased from JejuSamda Aloe (Jeju, Korea) in 2009 and 2010. Aloin A and aloin B were from ChromaDex (Irvine, USA) and were used as standards for aloe products. Mushroom and yeast β-glucan kits were from Megazyme (Wicklow, Ireland) and were used for β-glucan analysis. Levels of aloin A, aloin B and β-glucan were standardized by analyzing the aloe fermentation products for a general toxicity evaluation.
Cultivation conditions for strains and manufacturing of liquid spawn
Manufactured strains of Ganoderma lucidum and Phellinus linteus (in all liquid cultures) were incubated in PDA medium for 7 days at 28 o C. Strain discs were created by cutting with a cork borer (8 mm in diameter). Five to six discs were placed in an Erlenmeyer flask which contained 100 mL of potato dextrose broth (PDB, Difco) medium, and then were shaken and cultured (SI-400R; Jeiotech, Daejeon, Korea) for 6 days. The culture was then homogenized using a grinder. Nine milliliters of this was subsequently placed in an Erlenmeyer flask in which 100 mL of PDB was left for 5 days. These were used as the main spawn. Hericium erinaceum was processed by the same method as above but the temperature was kept at 24 o C [18, 20] .
Cultivation of mushroom mycelium in aloe as a natural medium
To obtain the viscosity of aloe gel, fresh leaves were washed, peeled and ground. The gel was placed in a fermenter and sterilized for 20 min at 120 fermenter was rapidly cooled to 25 o C and the resulting aloe gel was used as a natural medium. Aloe fermentation products were obtained by cultivating 9% of the liquid spawn in the gel at an optimum temperature. These aloe fermentation products were extracted at 85 o C for 6 h, filtered using filter paper (Advantec 5A; Advantec, Tokyo, Japan), and then evaporated and freeze-dried (Ilshinbiobase, Dongducheon, Korea). The freeze dried aloe fermentation products were used as the experimental samples.
Aloin A and aloin B levels
The concentrations of aloin A and aloin B were determined using a high performance liquid chromatography system (Waters 2695; Waters, Milford, USA)-photodiode array detector (PDA, Waters 996; Waters) with a fixed YMC-PACK PRO C 18 (5 µm 4.6×150 mm AS12S05-1546WT) [21, 22] .
β-Glucan analysis
One hundred mg of aloe fermentation product was placed in a 50 mL glass test tube, and 1.5 mL of 37 % hydrochloride was added. A reaction was made to occur every 15 min for 45 min in a 30 o C water bath. Ten mL of distilled water was added and then reacted in boiling water for 5 min and the contents of the tube were stirred in a 100 o C water bath for 2 h. They were allowed to cool and then 2 N KOH (10 mL) was added. The contents were centrifuged at 3,000xg for 10 min and the supernatant was collected. Exo-1,3-β-glucosidase (0.1 mL) was added to an equal volume of supernatant. A reaction was made to occur at 40 o C for 60 min and total glucan was determined. Aloe fermentation product (100 mg) was placed in a 50 mL glass test tube and 2 M KOH (2 mL) was added and placed in an ice water bath for 20 min. Next, 1.2 M sodium acetate buffer (pH 3.8, 8 mL) and amyloglucosidase plus invertase (0.2 mL) were mixed and placed in a 40 o C water bath for 30 min. This was centrifuged at 3,000×g for 10 min. Then 200 mM sodium acetate buffer (pH 5.0) was added to the supernatant and α-glucan levels were determined. Glucose oxidase/peroxidase/ 4-amino-anipyrine (GOPOD) reagents (3 mL) were placed in each of the total glucan and the α-glucan analyzing flasks, and the flasks were placed in a 40 o C water bath for 20 min. Absorbance was observed at 510 nm and the β-glucan content (%) in the sample was calculated [14, 23] .
Manufacturing and applying aloe fermentation products
Three aloe fermentation products (Ganoderma lucidumaloe fermentation product (AG), Hericium erinaceum-aloe fermentation product (AH) and Phellinus linteus-aloe fermentation product (AP) were used for both single-dose toxicity and repeated-dose toxicity tests. The toxicity tests were performed for the validity of food safety. Three different dosages (1, 2 and 5 g/kg) and (0.5, 1 and 2 g/kg) of each experimental material (AG, AH and AP) were, respectively, used for single-dose and repeated-dose toxicity tests. They were orally administered.
Toxicity tests
For single-dose toxicity test, a total of 80 rats were assigned to vehicle, AG, AH and AP groups, with each group accounting for 3 dose levels of 4 mice each with a total of 10 groups. After 24-h fasting, the test materials, dissolved in purified water, were administered orally using a syringe with a Sonde needle. According to the guidelines of KFDA and Health and Welfare Department of Japan, the upper-limit dosage was set at 5 g/kg (3-dose levels of 1, 2 and 5 g/kg). Feed were provided after 4 h of test material administration, and toxicity was evaluated for a 2-week observation period [24] [25] [26] .
For repeated-dose toxicity tests, the general procedure followed was the same as the above indicated single-dose toxicity test except that the 3-dose levels used in repeateddose toxicity tests were 0.5, 1 or 2 g/kg without fasting. The animals were administered for 28 days, and 10 rats were in each group (a total of 100 rats).
Observation of clinical signs
Based on the Functional Observational Battery (FOB) tests, such as function of the automatic nervous system, home cage, open field behaviors, reaction to stimulation, alertness, vigilance, posture, walking and mortality examinations were done every day during the experimental period. In addition to general symptoms, body weight as well as feed and water intakes were observed and recorded every week. At the end of the trial, rats were anesthetized with ether, the abdomen was opened, and the animals were killed by bleeding. Organs were examined with the naked eyes.
Hematological analysis
Blood was collected from the abdominal artery into an EDTA tube (BD vacutainer, BD, Franklin Lakes, USA). Hematocrit, red blood cells (RBC) and RBC indices, platelets, white blood cells (WBC) and differential counts were analyzed using a hematology analyzer (Siemens Medical ADVIA 2120, Bayer, Leverkusen, Germany).
Blood biochemical analysis
Blood was collected from the abdominal artery into a test tube. After standing for 30 min, the blood was centrifuged for 10 min at 12,000 rpm and the serum was collected. Hepatic toxicity indices (alanine transaminase, ALT; aspartate transaminase, AST; alkaline phosphatase, ALP; total proteins, TP; albumin; total bilirubin, TB; glucose), lipid metabolism indices (total cholesterol, TC; triglycerides, TG), and renal toxicity indices (blood urea nitrogen, BUN; creatinine) were measured using a Clinical Analyzer (Hitachi 7080 Clinical Analyzer, Hitachi, Tokyo, Japan).
Histopathological findings
For histopathological findings, liver, lung, spleen, kidney, heart, testis, ovary, adrenal gland, thymus and brain were collected and fixed in 10% formalin for 3 days. Paraffinembedded tissue sections (4 µm in thickness) were stained with hematoxylin-eosin, and examined with a light microscope.
Statistics
The data were analyzed by Kruskal-Wallis ANOVA and are presented as the mean±SD.
Results and Discussion
The contents of aloin and β-D-glucan in the aloe fermentation products
Since aloin A and B are well known as major active ingredients in aloe species, we determined the concentration of aloin A and aloin B in aloe fermentation products AG, AH and AP. The contents of aloin A in control samples (aloe alone) or in fermented samples with AG, AH and AP, are indicated in Table 1 . Aloe fermentation with mushroom mycelia increased the aloin A content in the fermentation products with the highest level observed in AP followed by AH; AG had no effect. Similarly, aloin B proportions in all 3 mushroom mycelia-fermented products were significantly increased: AP>AH>AG.
Since β-D-glucan is a multi-functional polysaccharide isolated from aloe species, we examined whether fermentation treatment affected polysaccharide composition. While the difference in proportion of β-D-glucan between un-treated control and Ganoderma lucidum-fermented aloe (AG) were not significant, AH and AP caused a significantly lowered β-D-glucan content than control (Table 1) .
Toxic symptoms, clinical signs and mortality rates
In the present study, general symptoms, clinical signs and mortality rates were examined at the given doses of the aloe fermentation products as indicated in the Materials and Methods section at 0, 1, 3, and 7 h and then daily for 14 days after treatment. All the aloe fermentation products (AG, AH and AP) did not cause any symptoms or abnormal clinical signs, and no deaths were observed during the study period (data not shown). According to the results from the singledose toxicity study, we set the dosage levels at 0.5, 1 and 2 g/kg for repeated-dose toxicity test. In repeated-dose toxicity test, the results were similar: neither abnormal symptoms, nor deaths were observed (data not shown). The results indicate that AG, AH and AP even at upper-limit doses do not induce any apparent clinical signs.
Feed and water intakes and body weight gains
In single-dose toxicity test, there were no significant differences in the body weight gain of male and female rats treated with aloe fermentation products (data not shown). In repeated-dose toxicity study, daily feed intakes were within 20-30 g and 10-15 g in all groups of male and female animals, respectively. Also, daily water intakes changed within 25-45 mL and 18-30 mL in male and female rats, respectively. There were no differences in the feed and water consumptions between control and aloe fermentation products (AG, AH and AP)-treated groups.
In addition, there were no differences in body weight gains between control and treatment groups, ranging from 96.4 to 123.3 mg/day/rat regardless of the doses used (Figure 1 ), which may be in correlation with the feed and water intakes.
The above results for single-dose and repeated-dose toxicity tests suggest that the aloe fermentation products were not toxic to rats even at the highest (upper-limit) dose of 2 g/kg.
Organ weights
After 4 weeks of treatment, the weight of internal organs of rats was measured. Liver, kidneys, lung, heart, thymus, spleen, adrenal glands, and reproductive organs (testes and epididymides) of aloe fermentation products-treated male rats were not different from vehicle controls in all groups tested (Table 2) . Similarly, liver, kidneys, lung, heart, thymus, spleen, adrenal glands, and reproductive organs (uterus and overies) of female rats were not different between control and treatment groups (Table 3) .
Hematology
The effects of aloe fermentation products on hematological parameters were determined in order to evaluate whether the tested products influence the normal values of the blood composition and their contents. In comparison with the vehicle control, hematocrit, RBC counts and RBC indices (hemoglobin, MCV, MCH and MCHC), platelets, WBC counts and their proportions (%) were not changed by treatment with 3 aloe fermentation products in female rats (Table 4) as well as in male animals (data not shown).
Blood biochemistry
Sera were analyzed for the adverse effects (tissue injury and dysfunction) of aloe fermentation products on tissues and organs. Table 5 and 6 depicts blood biochemical Figure 1 . Changes in body weights of male and female rats fed aloe fermentation products during oral administration for 28 days. AG: aloe fermentation product from Ganoderma lucidum, AH: aloe fermentation product from Hericium erinaceum, AP: aloe fermentation product from Phellinus linteus. parameters of rats fed the aloe fermentation products. The test materials at 3 different doses did not affect the normal values of all 11 biochemical parameters in both males (Table  5) and females ( Table 6 ). The parameters cover hepatocytic injury (ALT and AST), cholestasis (ALP and TB), hepatocytic protein synthesis (TP and albumin), lipid metabolism (TC and TG), energy synthesis and storage (glucose), and renal dysfunction (BUN and creatinine).
Histopathological findings
Histopathological examination of the vital organs of the rats fed aloe fermention products for 4 weeks were determined using hematoxylin-eosin staining techniques. All 3 aloe fermention products did not induce any histological lesions in organs including liver, lung, spleen, kidneys, heart, testes, ovaries, adrenal glands, thymus and brain (data not shown). The intact histological findings under microscopic examination well correlates with the normal organ weights, hematology and blood biochemical parameters.
We obtained 3 aloe fermentation products by fermenting aloe with 3 mushroom mycelia: aloin A and B contents in AG from Ganoderma lucidum, AH from Hericium erinaceus (AH) and AP from Phellinus linteus greatly increased, while the β-glucan content significantly decreased. In the present studies, we investigated any possible toxicities of the 3 aloe fermentation products in rats following oral administration once (at doses of 1, 2 and 5 g/kg) or for 28 days (at doses of 0.5, 1 and 2 g/kg).
There was no significant difference in body weight gain between vehicle control and AG-, AH-or AP-treated rats. Also, significant changes in daily feed intake and water consumption were not observed. In hematological analysis, non of the parameters observed were affected by aloe fermentation products with mushroom mycelia, suggestive of no adverse effects on hematopoiesis of blood cells and their integrity. In blood biochemistry, none of the markers examined were affected by AG, AH or AP feeding. Similarly, there were no significant effects on damage and functional markers of the liver and kidneys. Supportive of the above parameters, histopathological findings confirmed that the aloe fermentation products did not cause any lesions in major internal organs. In conclusion, since no adverse effects of AG, AH or AP were observed in single-or repeated-dose toxicity tests, even at upper-limit doses, it is suggested that aloe fermentation products with mushroom mycelia possess long-term safety and could be candidates for the improvement of intestinal function and immunity.
